Rapid Increase in Deadly Respiratory Infections in China, Big Lockdown Expected | TDTV

China Insider TV
242 followers
240 Video Views·Jan 21, 2025
China is currently on a trajectory to become the world's leading epicenter for diseases.
Recent admissions from Beijing have highlighted a significant increase in cases of infectious
diseases, revealing potential weaknesses in their epidemic response strategies.
In a startling revelation, authorities recorded 72,475 cases, encompassing 16 distinct legally
recognized contagious diseases in just a week towards the end of November.
The majority of these cases were attributed to seasonal flu.
Adding to the concern, Vision China has broadcasted news of a severe outbreak of mycoplasma pneumonia.
This has raised alarms internationally, especially with reports from Shanghai of over
400,000 new infections in a single day.
According to the Beijing Center for Disease Control and Prevention's weekly update for
November 20, 2026, the five most prevalent illnesses were influenza, hand, foot, and
mouth disease, and other common viruses, accounting for 99.4% of the total infections.
The remaining cases were a mix of 11 less common diseases.
This escalating situation is alarming.
George Washington University, speaking on CNN, warned that the prevalence of these diseases
might indicate a resurgence of COVID-19.
While the Chinese government asserts that seasonal flu spikes are typical, the World
Health Organization has expressed skepticism regarding China's transparency about the
mycoplasma pneumonia outbreak.
Furthermore, Taiwan's CDC has issued warnings about seven simultaneous virus epidemics,
which are severely straining the healthcare system in China.
Overall, the dramatic increase in infectious diseases in Beijing, along with concerns about
the transparency of information and the capacity of the healthcare system, paints a distressing
picture of a potential public health crisis in China.
This situation poses not just a national threat but also raises the risk of another global
pandemic, the abnormality in China's illnesses.
An article in the esteemed journal Nature, published on November 27, sheds light on some
intriguing and unusual aspects of the recent surge in respiratory diseases in China.
The article makes several noteworthy observations.
Firstly, it points out an anomaly in what's driving the hospitalizations.
In contrast to other countries where influenza and respiratory syncytial virus, RSV, have
been the primary causes post-pandemic, in China, a large number of cases are attributed
to mycoplasma pneumonia, a bacterial pathogen.
This bacterium typically causes mild cases of walking pneumonia, but this year, it has
been leading to more severe cases, requiring hospital admission.
Secondly, it's unusual that m.
sure pneumonia is the primary cause of infections in this surge, as bacterial pneumonias are
generally secondary infections following a viral illness.
This deviation from the norm is not yet fully understood.
Moreover, the high rates of antibiotic resistance to this bacterium in China could be
exacerbating its harmful effects.
Another deviation from the usual pattern is the early timing of this surge, hitting its
peak in October instead of the winter months.
This could be due to decreased immunity following extended COVID-19 restrictions, though the
exact reasons are still uncertain.
Professor William Schaffner from Vanderbilt University's School of Medicine in Tennessee,
USA, adds further context.
He contrasts the situation in China with that in the U.S. and other western countries, where
last winter saw early outbreaks of influenza and RSV, along with a rise in COVID-19 cases,
but no significant increase in mycoplasma pneumonia.
He finds this difference striking, especially considering the seasonal pattern of mycoplasma
pneumonia and its impact on young children, sometimes leading to severe pneumonia from
simple respiratory infections.
The scale and severity of the outbreak in China are highly unusual and concerning.
Annie Sparrow, deputy professor at Mount Sinai's Econ School of Medicine in New York, in an
article dated November 28, hypothesizes that the surge in hospitalizations, particularly
among children in China, might be due to a combination of mycoplasma pneumonia and COVID-19,
which could result in more deadly outcomes.
She also points out concerns regarding antibiotic resistance in children.
Wang Quanyi, deputy director of Beijing's Center for Disease Control and Prevention,
indicated in a recent interview that this year's influenza peak in Beijing might arrive
early.
He noted that in current pediatric outpatient cases, mycoplasma pneumonia ranks fourth in
prevalence, following influenza, adenovirus, and RSV.
The information presented in these analyses raises questions about the official narrative
and suggests that the situation with pathogens in China might be more complex and concerning
than what is being publicly acknowledged.
CCP is lying to the international board, covering their incompetence.
On December 2, Mi Feng, a spokesperson for the National Health Commission of the Chinese
Communist Party, CCP, asserted that the current spike in acute respiratory diseases in China
is attributable to known pathogens, and no new or emerging infectious diseases have been
identified.
Contrasting this statement, Chinese Foreign Minister Wang Yi, while at the United Nations
headquarters in New York on November 29, described the situation as merely influenza and claimed,
perhaps inaccurately, that the epidemic was under control.
The escalating severity of the epidemic, including the emergence of severe cases like white
lung, is fueling skepticism among both the public and international observers.
Many find it hard to accept the official narrative that the outbreak is solely due to ordinary
flu or mycoplasma infection, leading to suspicions that the CCP might be concealing the true
extent and nature of the epidemic.
Feng Chongye, an associate professor at the University of Technology, Sydney, reflected
on the widespread distrust in the Chinese government's statements, especially considering
the risks associated with speaking out under China's new anti-espionage laws.
This lack of transparency is causing significant concern globally, particularly regarding the
unclear pneumonia situation in China and its potential international repercussions.
Taiwanese virologist He Meiqiang voiced concerns about the absence of detailed statistics,
especially concerning severe cases in children.
Adding to the controversy, on November 26, a Beijing insider known as Yang Qing, a pseudonym,
who is reportedly close to the Zhongnanhai leadership, disclosed that the CCP had directed
the downplaying of the epidemic, instructing officials to refer to it as ordinary flu or
by another name while deliberately avoiding any mention of COVID-19.
Amidst these developments, numerous Chinese netizens report that hospitals are refraining
from testing for COVID-19, adhering to a no-test, no-existence policy.
Some individuals describe experiencing symptoms consistent with COVID-19,
yet their tests return negative results.
Despite the intensifying epidemic, officials have had to publicly acknowledge the presence
of COVID-19 once more.
On November 30, the Beijing Center for Disease Prevention and Control announced that infectious
disease cases in Beijing had doubled from November 20 to 26 compared to the preceding
week, with influenza and COVID-19 being the primary concerns.
In light of these developments, on November 24, the State Council's Joint Prevention
and Control Mechanism warned of the risk of a COVID-19 resurgence this winter and the
following spring.
Consequently, on December 1, U.S. senators called on the Biden administration to consider
implementing a travel ban between the U.S. and China.
Feng Chongyi advised that the international community should exercise increased caution,
including taking preventive measures for individuals returning from China.
Furthermore, on December 1, residents in Guangdong and Sichuan noticed the reactivation
of the previously discontinued health code system, leading to renewed concerns.
However, some netizens have pointed out that this system was never fully phased out and
has been criticized for serving more as a surveillance tool than a public health measure.
These developments collectively suggest a pattern of obfuscation and misinformation
within the CCP's handling of the epidemic, raising questions about the veracity of the
official narrativa and the potential implications for both China and the global community.
When a China is preparing for another major lockdown.
On December 1, an announcement from the Yiwu government advising residents to stockpile
food supplies for over 10 days garnered significant attention online.
This advisory, aimed at bolstering emergency preparedness and enhancing grain storage at
community level, sparked worry among Chinese netizens.
Many wondered if this was a precursor to an impending lockdown, especially given the current
pandemic situation.
The timing of this recommendation in Yiwu was particularly noteworthy, as it coincided
with swirling rumors and speculations about a potential resurgence of the pandemic.
The advisory was later retracted from online platforms, adding to the intrigue and speculation.
In a related development, reports have surfaced about Shanghai airport initiating nucleic
acid testing for travelers.
This move comes after previous suspensions of health code systems, like the Yuekang code
in Guangdong.
However, recent checks have shown that these systems are still in place, fueling various
theories and conjectures.
The recent spike in large-scale mycoplasma pneumonia infections in China has been flagged
as highly unusual by medical experts, including Professor William Schaffner from Vanderbilt
University.
This outbreak is noteworthy not only for its severity, but also for the scale of its spread,
which is atypical.
Chinese authorities have noted that various viruses are affecting different age groups
with a significant presence of COVID-19 in numerous cases.
This is despite the limited coverage of this aspect by official media.
There are also unverified reports suggesting that there might be directives to underplay
the severity of the COVID-19 situation.
Amidst the rapidly worsening epidemic across various regions, preventative measures are
being reintroduced.
For instance, He Xiaopeng, the chairman of Xiaopeng Motors, revealed that he had to undergo
nucleic acid testing upon his return to Shanghai from abroad.
Additionally, recent events in Sanhei City, Hebei, including the mobilization of health
workers in protective gear for disinfecting schools, have heightened public fears.
These measures evoke memories of the harsh lockdowns that severely impacted China's
economy and disrupted the lives of millions.
The re-emergence of these stringent measures and the potential for more lockdowns present
a worrying scenario not just for the people in China, but also for the global community.
Given China's integral role in the world economy and global health landscape,
Beijing relies on ineffective traditional Chinese medicine.
In the midst of a rapid escalation of COVID-19 cases across China, the government in Beijing
is reverting to a well-worn but contentious strategy, the vigorous promotion of traditional
Chinese medicine, TCM, as a treatment method.
On December 2, the Chinese National Health Commission extolled the virtues of TCM at
a press conference, claiming it has a substantial therapeutic effect on respiratory diseases,
including COVID-19.
They disclosed plans to collaborate with the state administration of traditional Chinese
medicine to enhance the availability of TCM treatments this winter.
This endorsement of TCM, particularly in the face of a surge in infections, rekindles uncomfortable
memories of the earlier stringent lockdowns for many Chinese residents.
During China's stringent adherence to its zero-COVID policy, the government mandated
the use of TCM as a political task, urging citizens to utilize products like Lianhua
Qingwen, despite the absence of solid scientific backing.
However, as widely acknowledged by the public now, consuming these herbal remedies often
proved to be more beneficial to those with financial stakes in the TCM industry than
to those suffering from the virus.
The aggressive promotion of TCM served more as a governmental propaganda tool than as
an effective means of providing substantial relief to the millions of frustrated and quarantined
individuals yearning for a return to normalcy.
The reemergence of state-endorsed, dubious TCM treatments in the context of skyrocketing
cases, many of which are attributed to the unchecked spread of newer COVID variants,
is seen as a regressive step.
After enduring three years of lockdowns and having our lives disrupted by unscientific
pandemic policies, the reintroduction of TCM indicates that the authorities haven't
assimilated any lessons and continue to disregard concrete data when making decisions of such
significant human impact, commented an epidemiologist from Shanghai, who chose to remain anonymous
due to the politically sensitive nature of the topic.
Global public health experts consistently agree that proven medical treatments and vaccines,
not traditional plant-based remedies, are the key instruments in combating the COVID-19
pandemic.
However, Beijing seems resistant to acknowledging this reality, with ideological stances potentially
overriding scientific diligence once more as the situation worsens.
For many families who have borne the brunt of these ill-advised policies, the unfortunate
reality is that facts- and evidence-based approaches still seem to take a back seat
in the face of rigid governmental ideology.
Chinese are fleeing en masse.
Recent data indicates a significant uptick in capital outflows from China, with September
witnessing net outflows of $53.9 billion, the highest since the $55.8 billion recorded
in January 2016, which were primarily driven by concerns over the devaluation of the Renminbi
RMB.
These outflows are distinctly linked to direct investments, such as factory construction,
amounting to $26.2 billion, and to securities including stocks and bonds, totaling $14.6
billion.
This trend of net outflows has been consistent since February 2022.
August saw capital account outflows from China reaching $49 billion a peak, not observed
since December 2015.
This significant withdrawal of funds has also contributed to the RMB dollar exchange rate
plummeting to a 16-year low.
This pattern suggests that Chinese elites are proactively transferring substantial amounts
of capital overseas.
As uncertainties continue to escalate within China, an increasing number of wealthy Chinese
individuals are relocating assets abroad, possibly to evade potential targeting by the
Chinese Communist Party, CCP, amid escalating lockdowns and restrictions.
Michael Sun, a senior Chinese investment strategist and private wealth advisor, emphasized
the urgency of this situation in a December 1st interview.
It's a clear signal.
Escape.
The lack of confidence in the CCP leadership is evident, regardless of their efforts in
regions like Shanghai.
Further underscoring this trend is the acceleration of immigration from China under Xi Jinping's
increasingly authoritarian regime.
Stringent COVID-19 lockdowns, a faltering economy, and heightened political persecution
are driving record numbers of Chinese citizens to seek asylum in foreign lands.
Data from the UN Refugee Agency shows a significant rise in the number of Chinese
individuals living abroad with refugee status, over 170,000 compared to just 120,000 in 2012
when Xi Jinping assumed power.
Projections for 2023 suggest a further increase, with an estimated 310,000 Chinese expected
to emigrate as Xi's control intensifies.
To accommodate this growing exodus, new migration routes are emerging.
Chinese nationals are now the fourth largest group traversing the perilous Darien Gap jungle
into Panama en route to the U.S. southern border.
Additionally, there has been a notable increase in Chinese asylum applications in the European
Union, with Germany emerging as a prime destination for those navigating the Balkan migrant trail
through southeastern Europe.
The United States and Europe are popular refugees due to their more comprehensive asylum systems.
However, even Asian countries like South Korea and Thailand are observing a rise in Chinese
asylum seekers.
As China grapples with stagnant economic growth and escalating political repression under
Xi, immigration is becoming a vital outlet for both dissidents and ordinary citizens.
Consequently, the world is likely to witness continuing waves of Chinese migrants seeking
safer and freer lives abroad.
This mass migration presents a concerning scenario, not only for China, but for the
global community.
Should the situation in China not improve, the world may face rapid and widespread chaos,
exacerbated by the ongoing COVID-19 pandemic and the large-scale exodus from the mainland.
